Chinese Tech Earnings Season Kicks Off: Will JD.com, Tencent, or Alibaba Lead the Rally?
Amid rising expectations for US tariff negotiations, high-tech shares lead the increase.
The Nikkei average rebounded, ending the trade at 36,928.63 yen, up 148.97 yen (with an estimated Volume of 1.9 billion 10 million shares). The U.S. Federal Open Market Committee (FOMC) passed quietly, and supported by the rise in U.S. stocks and the progress of yen depreciation, the main technology stocks opened with Buy orders. After the initial surge in buying, the market softened due to profit-taking and other selling, with a drop to 36,606.71 yen observed at one point. Later, U.S. President Trump stated that 'regarding trade agreements with major countries, there will be an announcement at 10 AM on the 8th (Japan time).
Under the "safety equality" context, prices have dramatically dropped. Will Lidar make a comeback in vehicles?
① The 2025 Avita 12 is launched with the "three Lidar solution", which is currently the only "three Lidar" case in the 0.3 million level; ② The deepening Global Strategy cooperation reached a month ago between LEAPMOTOR and Hesai Technology also focuses on "Lidar".
Cathie Wood Strengthens AI Chip Holdings With Nvidia And AMD Purchases, Reduces Palantir Position By Another $38.8 Million
The market's long and short game has entered a phase of intense competition, and in the short term, it may continue to rotate around the three hot directions of chemicals, Siasun Robot&Automation, and AI.
Track the entire lifecycle of the main Sector.
Palantir Shares Fall Despite Strong Q1 Earnings, Raised Guidance: What's Going On?
Alphabet Leaps Over Nvidia, Tesla in Top Stock Options as AI Threatens Search Revenue: Options Chatter
SA Analyst Upgrades: TSLA, MSFT, AMD, PLTR, VRTX, ONON, CB
Enterprise Stocks Mixed After Jamf, Teradata Earnings Results
Alibaba Cloud has dropped another bombshell.
Rushing towards the AI empire.
Palantir Chart Showing 'Classic Double Top' - BTIG
TRADER’SEDGE (7May 2025) - Tech Weakness and Trade War Fears Drag Markets Lower Amid Economic Uncertainty
Cathie Wood Sells $41 Million Worth Of Palantir Shares Following Post-Earnings Plunge
Express News | In Overnight Trading, U.S.-Listed Chinese Stocks and ETFs Surge After China's Official Announces Series of Policies; DUO Surges 17%, BEKE Rises 4%; Alibaba, JD and Bilibili Rise 2%, YINN Up 4%, CWEB Rises 3%
Direct coverage of the Earnings Conference for the Siasun Robot&Automation Industry: The localization rate of the supply chain is accelerating, while the industrial sector still faces fierce competition.
① Many companies participating in the performance briefing stated that currently, the core or most supply chain links have been localized, while a small number of links that require imports are actively planning localization solutions; ② From the perspective of the overall Siasun Robot&Automation Industry, the competition in the industrial robot industry is fierce, and in 2024, a situation of "growth in quantity without growth in revenue, and growth in revenue without growth in profit" may occur.
The A-share International Board under ANT GROUP CO., LTD. may launch an IPO.
① After the Listing As a Whole of ANT GROUP CO., LTD. was put on hold, ANT International, registered in Singapore, may consider a separate listing in Hong Kong. Discussions with relevant authorities regarding this possibility are currently underway. ② Recently, ANT International also issued a letter to all employees, requiring cost control and efficiency improvements. On March 19, 2024, ANT International will be spun off from ANT GROUP CO., LTD. to operate independently in the market. One significant meaning of the spin-off from ANT GROUP CO., LTD. is the ability to independently finance and bear profits and losses.
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
Palantir Analysts Boost Their Forecasts After Q1 Results
Palantir Stock A 'Core Name In AI Revolution': Analysts Expect $1 Trillion Market Cap In 3 Years
Hims & Hers Joins Nvidia, Tesla, Apple in Most Active Stock Options: Options Chatter